What top creators are saying about Exelixis, Inc.(EXEL)
Genomics-based drug discovery company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Exelixis, Inc..
Top creators covering Exelixis, Inc. (EXEL)
The 1 sources with the most insights about Exelixis, Inc. on Kazuha.
Latest insights about Exelixis, Inc. (EXEL)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
Described as a 'dog'; main drug has likely peaked and pipeline candidates are facing study failures.
Yesterday
Described as a 'dog'; main drug has likely peaked and pipeline candidates are facing study failures.
Discussed alongside Exelixis, Inc. (EXEL)
Other assets that creators frequently mention in the same content as Exelixis, Inc..
Frequently asked
Which podcasters and creators cover Exelixis, Inc. (EXEL) the most?
The most active sources covering Exelixis, Inc. (EXEL) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Exelixis, Inc. (EXEL) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Exelixis, Inc. (EXEL) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Exelixis, Inc. (EXEL)?
Creators covering Exelixis, Inc. (EXEL) most frequently also discuss MU, ABT, AMZN, INMB, ABVX. See the "Discussed alongside" section above for full asset pages.